Lymphoma Rounds at Lymphoma, Leukemia & Myeloma Congress

Please note that this page is for Virtual registration only. If you would like to attend in person, please register Here.

Date & Time
Wednesday, October 15, 2025
7:00 PM (UTC-04:00) Eastern Time (US & Canada)
In-Person Networking/Cocktail Hour begins 6:00 PM Eastern Time  
 
Duration
90 minutes
 
Intended Learners

Practicing lymphoma healthcare providers (e.g. Hematologist/Oncologists, Physicians, Pathologists, Fellows, Residents, Medical Students, Pharmacists, Physician’s Assistants, Nurse Practitioners, Nurses, Other Healthcare Providers).

 
Learning Objectives

The Lymphoma Rounds program provides a forum for practicing physicians from academic and community medical centers to meet throughout the academic year and address issues specific to the diagnosis and treatment of their lymphoma patients. Physicians network, share best practices and learn the latest information on new therapies and advances in the management of lymphoma through interactive case studies presented by lymphoma experts.

At the conclusion of this activity, learners should better be able to:

  • Summarize the latest developments in lymphoma diagnosis, treatment, and management
  • Apply best practices for treating lymphoma patients
  • Inform patients about potential clinical trial opportunities
  • Network with fellow healthcare professionals 

 

Disclaimer: The Lymphoma Research Foundation is a national nonprofit organization based in the United States (U.S.) with educational programs and resources which are intended for a U.S. based audience. These programs and resources are intended for educational purposes only and are not a substitute for medical advice. Individuals who use Foundation programs and services are advised to consult a medical professional for medical advice, diagnoses, or treatment. Foundation programs and resources address available lymphoma/CLL treatments in the United States and information on drug approvals by the U.S. Food and Drug Administration (FDA). The Foundation does not endorse any treatments, products, or services mentioned in its resources. The information provided is for informational purposes only and should not be considered as an endorsement. The Foundation shall not be liable for any direct, indirect, incidental, special, consequential, or punitive damages arising out of the use of its programs and resources, to the extent permitted by law. You assume full responsibility for any actions taken based on the information provided. For individuals outside of the U.S. seeking information, the Foundation recommends the Lymphoma Coalition. The Lymphoma Coalition is a global network of worldwide nonprofit/NGO lymphoma patient organizations with information appropriate for non-U.S.-based audiences. Additional information can be found by visiting their website at https://lymphomacoalition.org. All content provided by the Foundation is protected by intellectual property laws. You may not reproduce, distribute, or otherwise use the content without the Foundation's prior written consent.

 
 

Faculty

James Gerson, MD
James Gerson, MD
University of Vermont Larner College of Medicine
Associated Professor of Medicine

Mark Roschewski, MD
Mark Roschewski, MD
National Institutes of Health/National Cancer Institutes
Senior Clinician

Eduardo M. Sotomayor, MD
Eduardo M. Sotomayor, MD
Tampa General Hospital Cancer Institute
Vice President and Executive Director

Dr. Andrew H. Lipsky
Dr. Andrew H. Lipsky
Columbia University Medical Center
Assistant Professor of Medicine

Continuing Education

 

 

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the University of Cincinnati and Lymphoma Research Foundation. The University of Cincinnati is accredited by the ACCME to provide continuing medical education for physicians.

Physician Credit Designation Statement (AMA) LIVE/VIRTUAL LIVE: The University of Cincinnati designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.